We completed layoffs yesterday at Ginkgo and had to let go of many truly excellent Bioworkers. This was the hardest change we've made at @Ginkgo and it's on myself and leadership for the decisions that led up to it. People come to Ginkgo because they want to develop new technologies at the very edge of what is possible in biological engineering, DNA design tools, automation, and more. Thus these are truly amazing folks with unique skills -- they are lifelong alumni of Ginkgo and we are very sad to be losing them and you should be very happy to hire them! If you'd like to post job openings you can join this LinkedIn group that includes recently departed Ginkgo folks where you can post open roles: linkedin.com/groups/13041413… Ginkgo has been focused over the last couple of weeks on doing right by our departing employees. Now we will be looking forward. Ginkgo remains very well capitalized, ending the first quarter with nearly $850M in cash and essentially no debt, staffed with incredible talent and containing an unparalleled aggregation of technology in bioengineering from automation to AI. I’m deeply thankful for the incredible effort that has gone into building the assets we have today, especially from departing employees, and we will make the most of them as we continue to make biology easier to engineer.